Millrace Asset Group, Inc. Ligand Pharmaceuticals Inc Transaction History

Millrace Asset Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$80.55 - $106.05 $788,423 - $1.04 Million	-9,788 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$89.56 - $126.72 $489,534 - $692,651	-5,466 Reduced 35.83%	9,788 $933,000
Q2 2020 Aug 13, 2020	BUY	$68.28 - $123.65 $1.04 Million - $1.89 Million	15,254 New	15,254 $1.71 Million
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $1.18 Million - $1.64 Million	-13,671 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$107.38 - $129.34 $464,848 - $559,912	-4,329 Reduced 24.05%	13,671 $1.56 Million
Q1 2019 May 14, 2019	BUY	$105.93 - $142.47 $1.91 Million - $2.56 Million	18,000 New	18,000 $2.26 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Millrace Asset Group, Inc. with notifications on news.